Richard C Burgess, MD | |
9500 Euclid Ave, Suite S-51, Cleveland, OH 44195-0001 | |
(800) 223-2273 | |
Not Available |
Full Name | Richard C Burgess |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 9500 Euclid Ave, Cleveland, Ohio |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003852757 | NPI | - | NPPES |
0785100 | Medicaid | OH | |
130014646 | Other | OH | MEDICARE RAILROAD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084N0400X | Psychiatry & Neurology - Neurology | 35042534 (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Richard C Burgess, MD 6000 W Creek Rd, Suite 10, Independence, OH 44131-2139 Ph: (800) 223-2273 | Richard C Burgess, MD 9500 Euclid Ave, Suite S-51, Cleveland, OH 44195-0001 Ph: (800) 223-2273 |
News Archive
One of the most common initial red flags reported by parents of children with autism is that they suspect their child may be deaf because he or she no longer responds to his or her name, and does not look at them when they speak. However, the lack of response or eye contact can point to an Autism Spectrum Disorder. In fact, many children on the autism spectrum do not demonstrate typical language skills and social behavior, or even lose language or social skills they once had.
In the end it was the delta variant that drove Rose Mitchell, 89, down the winding mountain road to the Full Gospel Church of Jesus Christ to get the shot. Her pastor, Billy Joe Lewis, had told his congregation that, No, ma'am, a covid vaccine would not leave the "mark of the beast" nor rewrite their genetic codes.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) has notified the Company that its new biologic license application (BLA) for ocriplasmin intravitreal injection will be discussed at the Dermatologic and Ophthalmic Drugs Advisory Committee scheduled for July 26, 2012.
ARIAD Pharmaceuticals, Inc. today announced it has completed the rolling submission of the New Drug Application (NDA) for its investigational BCR-ABL inhibitor, ponatinib, to the U.S. Food and Drug Administration (FDA).
University of Alabama at Birmingham cardiovascular physician Tom McElderry, M.D., has become the first surgeon in the United States to use the new IntellaTip MiFiā¢ XP catheter in a patient.
› Verified 2 days ago
Mr. Apisit Boongird, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 12000 Fairhill Rd Apt 813, Cleveland, OH 44120 Phone: 216-526-2014 | |
Rachel Sieke, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, None, Cleveland, OH 44195 Phone: 717-880-7438 | |
Keming Gao, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 11100 Euclid Ave, Cleveland, OH 44106 Phone: 216-844-2400 | |
Richard J Lederman, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 800-223-2273 | |
Joseph Michael Austerman, D. O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 216-444-2200 Fax: 216-444-9054 | |
Robert J Marquardt, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 216-444-2200 Fax: 216-445-9908 |